2-Deoxyglucose Suppresses ERK Phosphorylation in LKB1 and Ras Wild-Type Non-Small Cell Lung Cancer Cells

Linlin Sun1, Xiuju Liu2, Haian Fu3

  • 1Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin, P.R. China.

Plos One
|December 30, 2016
PubMed

Insights

The glycolytic inhibitor 2-deoxyglucose (2-DG) suppresses ERK phosphorylation in lung cancer cells via the LKB1/AMPK pathway. This reveals a novel cross-talk between metabolic regulation and cancer signaling.

Area of Science:

  • Cellular metabolism
  • Cancer biology
  • Signal transduction

Background:

  • Tumor cells exhibit aerobic glycolysis (Warburg effect) for ATP production.
  • 2-deoxyglucose (2-DG) is a known glycolytic inhibitor.
  • The precise impact of 2-DG on cellular signaling pathways, particularly ERK, remains unclear.

Purpose of the Study:

  • To investigate the effect of 2-DG on ERK phosphorylation in lung cancer cells.
  • To elucidate the underlying molecular mechanisms, including the role of LKB1 and AMPK.

Main Methods:

  • Time- and dose-dependent analysis of ERK phosphorylation in response to 2-DG.
  • LKB1 knockdown and restoration experiments in lung cancer cells.
  • Assessment of AMPK pathway involvement using inhibitors and siRNA.
  • Investigation of upstream regulators like K-Ras and IGF1.

Main Results:

  • 2-DG inhibits ERK phosphorylation in a time- and dose-dependent manner.
  • This inhibition is dependent on functional Liver Kinase B1 (LKB1).
  • 2-DG-induced ERK inhibition is mediated by the LKB1/AMPK signaling pathway.
  • Insulin-like Growth Factor 1 (IGF1)-induced ERK phosphorylation is reduced by 2-DG.
  • Certain oncogenic K-Ras mutants interfere with 2-DG-mediated LKB1/AMPK signaling.

Conclusions:

  • 2-DG exerts its inhibitory effect on ERK phosphorylation through the LKB1/AMPK pathway.
  • A significant cross-talk exists between LKB1/AMPK metabolic signaling and ERK pathway activation in lung cancer.
  • These findings enhance the understanding of 2-DG's mechanism of action and its potential in cancer therapy.

Related Concept Videos

Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.6K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.9K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K